Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SPRB

+ Watchlist+ Portfolio

Spruce Biosciences, Inc.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$40.84
52-Week Range
$38.06 – $115.00
Market Cap
$116.37M
P/E (TTM)
—
EPS (TTM)
-33.29
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.76
PEG Ratio
—
Return on Equity
-187.35%
Return on Assets
-54.17%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
4.83
Debt/Equity
0.13
Total Debt
$8.32M
Free Cash Flow
$-18.05M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$37.00M

Market Snapshot

About

Spruce Biosciences is a biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is advancing tildacerfont, an investigational therapy for patients with congenital adrenal hyperplasia, a rare genetic disorder affecting cortisol production.